Lets be realistic .....longs have "married" the stock. Great progress and huge potential, thanks to Joe and his team. Newbies looking in from the outside..........no nasdaq yet, several LOI's (maybe, maybe not), AE37 clinical trial - completion scheduled for 2023/24 - many ph2 abandoned if expectations not met, no significant revenues, low volume trading days, no institutional buying.
Im long and patient , new investors dont mind to pay above 5 or even 2 digits if company is successful and revenues reported. They dont care about the 1:1 , most likely price will drop after Oct 30 , if not they will pay a little more. GNBT is a longterm investment !!